Importantly, CDK1 was identified to be upregulated in a variety of malignant tumors, such as colorectal cancer (33), prostate cancer (34), bladder cancer (35), ovarian cancer (36), and breast cancer (37). This evidence concerns the gene CDK1 and urinary bladder cancer.